Michael Mason, EVP, CFO & Treasurer at Karyopharm Therapeutics Inc. (KPTI), sold 4,205 shares at $1.59 ($7K) on 2024-02-06, disclosed to the SEC on 2024-02-08.
Seasonal sale ($7k) by EVP, CFO & Treasurer — this insider has traded KPTI in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| KPTI | SELL | 2024-03-04 | $40K | — | Filing → |
| KPTI | SELL | 2024-02-29 | $3K | — | Filing → |
| KPTI | SELL | 2023-09-05 | $9K | — | Filing → |